Role of NUCB2/Nesfatin-1 in the hypothalamic control of energy homeostasis

Hormone and Metabolic Research

Volumn 45, Issue 13, 2013, Pages 975-979

  Stengel, A ^a   Tache Y ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

body weight; food intake; hypothalamus; nesfatin 1; NUCB2; obesity; satiation

Indexed keywords

ANOREXIGENIC AGENT; NESFATIN 1; NEUROTRANSMITTER; NUCLEOBINDIN 2; UNCLASSIFIED DRUG;

ARCUATE NUCLEUS; ARTICLE; BIOLOGICAL ACTIVITY; BODY WEIGHT; CENTRAL NUCLEUS (AMYGDALA); CEREBELLUM; CIRCADIAN RHYTHM; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; EDINGER WESTPHAL NUCLEUS; FEEDING; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; HUNGER; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; INSULA; LATERAL BRAIN VENTRICLE; LATERAL HYPOTHALAMUS; LOCUS CERULEUS; NEUROMODULATION; NONHUMAN; PARASYMPATHETIC NERVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAPHE NUCLEUS; REGULATORY MECHANISM; SATIETY; SIGNAL TRANSDUCTION; SPINAL CORD; SUPRAOPTIC NUCLEUS; THALAMUS VENTRAL NUCLEUS; TUBERAL NUCLEUS; WEIGHT CONTROL;

RATTUS;

ANIMALS; BODY WEIGHT; CALCIUM-BINDING PROTEINS; DNA-BINDING PROTEINS; EATING; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; HYPOTHALAMUS; NERVE TISSUE PROTEINS; RATS;

EID: 84890553223     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1351324     Document Type: Article

References (51)

1. Oh-I S., Shimizu H., Satoh T., Okada S., Adachi S., Inoue K., Eguchi H., Yamamoto M., Imaki T., Hashimoto K., Tsuchiya T., Monden T., Horiguchi K., Yamada M., Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature: 2006; 443 709 712 (Pubitemid 44564715)
2. Mohan H., Unniappan S. Phylogenetic Aspects of Nucleobindin-2/Nesfatin-1. Curr Pharm Des: 2013; [Epub ahead of print]
3. Tsuchiya T., Shimizu H., Yamada M., Osaki A., Oh I. S., Ariyama Y., Takahashi H., Okada S., Hashimoto K., Satoh T., Kojima M., Mori M. Fasting Concentrations of Nesfatin-1 Are Negatively Correlated with Body Mass Index in Non-Obese Males. Clin Endocrinol (Oxf): 2010; 73 484 490
4. Foo K., Brismar H., Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience: 2008; 156 563 579
5. Stengel A., Goebel M., Yakubov I., Wang L., Witcher D., Coskun T., Taché Y., Sachs G., Lambrecht N. W. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology: 2009; 150 232 238
6. Gonzalez R., Kerbel B., Chun A., Unniappan S. Molecular, cellular and physiological evidences for the anorexigenic actions of nesfatin-1 in goldfish. PLoS One: 2010; 5 e15201
7. Brailoiu G. C., Dun S. L., Brailoiu E., Inan S., Yang J., Chang J. K., Dun N. J. Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology: 2007; 148 5088 5094 (Pubitemid 47481535)
8. Kohno D., Nakata M., Maejima Y., Shimizu H., Sedbazar U., Yoshida N., Dezaki K., Onaka T., Mori M., Yada T. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology: 2008; 149 1295 1301 (Pubitemid 351397928)
9. Goebel M., Stengel A., Wang L., Lambrecht N. W., Taché Y. Nesfatin-1 immunoreactivity in rat brain and spinal cord autonomic nuclei. Neurosci Lett: 2009; 452 241 246
10. Goebel-Stengel M., Wang L., Stengel A., Taché Y. Localization of nesfatin-1 neurons in the mouse brain and functional implication. Brain Res: 2011; 1396 20 34
11. Bustos G., Abarca J., Campusano J., Bustos V., Noriega V., Aliaga E. Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain. Brain Res Brain Res Rev: 2004; 47 126 144 (Pubitemid 39574316)
12. Landgraf R., Neumann I. D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front Neuroendocrinol: 2004; 25 150 176 (Pubitemid 39642188)
13. Stengel A., Hofmann T., Goebel-Stengel M., Lembke V., Ahnis A., Elbelt U., Lambrecht NW G., Ordemann J., Klapp B. F., Kobelt P. Ghrelin and NUCB2/nesfatin-1 are expressed in the same gastric cell and differentially correlated with body mass index in obese patients. Histochem Cell Biol: 2013; 139 909 918
14. Ishida E., Hashimoto K., Shimizu H., Okada S., Satoh T., Kato I., Yamada M., Mori M. Nesfatin-1 induces the phosphorylation levels of cAMP response element-binding protein for intracellular signaling in a neural cell line. PLoS One: 2012; 7 e50918
15. Maejima Y., Sedbazar U., Suyama S., Kohno D., Onaka T., Takano E., Yoshida N., Koike M., Uchiyama Y., Fujiwara K., Yashiro T., Horvath T. L., Dietrich M. O., Tanaka S., Dezaki K., Oh I. S., Hashimoto K., Shimizu H., Nakata M., Mori M., Yada T. Nesfatin-1-regulated oxytocinergic signaling in the paraventricular nucleus causes anorexia through a leptin-independent melanocortin pathway. Cell Metab: 2009; 10 355 365
16. Xia Z. F., Fritze D. M., Li J. Y., Chai B., Zhang C., Zhang W., Mulholland M. W. Nesfatin-1 inhibits gastric acid secretion via a central vagal mechanism in rats. Am J Physiol Gastrointest Liver Physiol: 2012; 303 G570 G577
17. Iwasaki Y., Nakabayashi H., Kakei M., Shimizu H., Mori M., Yada T. Nesfatin-1 evokes Ca2+ signaling in isolated vagal afferent neurons via Ca2+ influx through N-type channels. Biochem Biophys Res Commun: 2009; 390 958 962
18. Fort P., Salvert D., Hanriot L., Jego S., Shimizu H., Hashimoto K., Mori M., Luppi P. H. The satiety molecule nesfatin-1 is co-expressed with melanin concentrating hormone in tuberal hypothalamic neurons of the rat. Neuroscience: 2008; 155 174 181
19. Inhoff T., Stengel A., Peter L., Goebel M., Taché Y., Bannert N., Wiedenmann B., Klapp B. F., Mönnikes H., Kobelt P. Novel insight in distribution of nesfatin-1 and phospho-mTOR in the arcuate nucleus of the hypothalamus of rats. Peptides: 2010; 31 257 262
20. Inhoff T., Mönnikes H., Noetzel S., Stengel A., Goebel M., Dinh Q. T., Riedl A., Bannert N., Wisser A. S., Wiedenmann B., Klapp B. F., Taché Y., Kobelt P. Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats. Peptides: 2008; 29 2159 2168 (Pubitemid 50320433)
21. Gaige S., Bonnet M. S., Tardivel C., Pinton P., Trouslard J., Jean A., Guzylack L., Troadec J. D., Dallaporta M. c-Fos immunoreactivity in the pig brain following deoxynivalenol intoxication: focus on NUCB2/nesfatin-1 expressing neurons. Neurotoxicology: 2013; 34 135 149
22. Okere B., Xu L., Roubos E. W., Sonetti D., Kozicz T. Restraint stress alters the secretory activity of neurons co-expressing urocortin-1, cocaine- and amphetamine-regulated transcript peptide and nesfatin-1 in the mouse Edinger-Westphal nucleus. Brain Res: 2010; 1317C 92 99
23. Stengel A., Goebel M., Taché Y. Nesfatin-1: a novel inhibitory regulator of food intake and body weight. Obes Rev: 2011; 12 261 271
24. Goebel M., Stengel A., Wang L., Taché Y. Central nesfatin-1 reduces the nocturnal food intake in mice by reducing meal size and increasing inter-meal intervals. Peptides: 2011; 32 36 43
25. Stengel A., Goebel M., Wang L., Rivier J., Kobelt P., Mönnikes H., Lambrecht N. W., Taché Y. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin- releasing factor2 receptor. Endocrinology: 2009; 150 4911 4919
26. Yosten G. L., Samson W. K. The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist. Am J Physiol Regul Integr Comp Physiol: 2010; 298 R1642 R1647
27. Atsuchi K., Asakawa A., Ushikai M., Ataka K., Tsai M., Koyama K., Sato Y., Kato I., Fujimiya M., Inui A. Centrally administered nesfatin-1 inhibits feeding behaviour and gastroduodenal motility in mice. Neuroreport: 2010; 21 1008 1011
28. Konczol K., Pinter O., Ferenczi S., Varga J., Kovacs K., Palkovits M., Zelena D., Toth Z. E. Nesfatin-1 exerts long-term effect on food intake and body temperature. Int J Obes (Lond): 2012; 36 1514 1521
29. Kerbel B., Unniappan S. Nesfatin-1 suppresses energy intake, co-localises ghrelin in the brain and gut, and alters ghrelin, cholecystokinin and orexin mRNA expression in goldfish. J Neuroendocrinol: 2012; 24 366 377
30. Merali Z., Cayer C., Kent P., Anisman H. Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology (Berl): 2008; 201 115 123
31. Yosten G. L., Samson W. K. Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system. Am J Physiol Regul Integr Comp Physiol: 2009; 297 R330 R336
32. Chen X., Dong J., Jiang Z. Y. Nesfatin-1 influences the excitability of glucosensing neurons in the hypothalamic nuclei and inhibits the food intake. Regul Pept: 2012; 177 21 26
33. Stengel A., Goebel-Stengel M., Wang L., Kato I., Mori M., Taché Y. Nesfatin-1(30-59) but not the N- and C-terminal fragments, nesfatin-1(1-29) and nesfatin-1(60-82) injected intracerebroventricularly decreases dark phase food intake by increasing inter-meal intervals in mice. Peptides: 2012; 35 143 148
34. Sedbazar U., Maejima Y., Nakata M., Mori M., Yada T. Paraventricular NUCB2/nesfatin-1 rises in synchrony with feeding suppression during early light phase in rats. Biochem Biophys Res Commun: 2013; 434 434 438
35. Yosten G. L., Redlinger L., Samson W. K. Evidence for a role of endogenous nesfatin-1 in the control of water drinking. J Neuroendocrinol: 2012; 24 1078 1084
36. Garcia-Galiano D., Navarro V. M., Roa J., Ruiz-Pino F., Sanchez-Garrido M. A., Pineda R., Castellano J. M., Romero M., Aguilar E., Gaytan F., Dieguez C., Pinilla L., Tena-Sempere M. The anorexigenic neuropeptide, nesfatin-1, is indispensable for normal puberty onset in the female rat. J Neurosci: 2010; 30 7783 7792
37. Miyata S., Yamada N., Kawada T. Possible involvement of hypothalamic nucleobindin-2 in hyperphagic feeding in Tsumura Suzuki obese diabetes mice. Biol Pharm Bull: 2012; 35 1784 1793
38. Ogiso K., Asakawa A., Amitani H., Nakahara T., Ushikai M., Haruta I., Koyama K. I., Amitani M., Harada T., Yasuhara D., Inui A. Plasma nesfatin-1 concentrations in restricting-type anorexia nervosa. Peptides: 2011; 32 150 153
39. Ramanjaneya M., Chen J., Brown J. E., Tripathi G., Hallschmid M., Patel S., Kern W., Hillhouse E. W., Lehnert H., Tan B. K., Randeva H. S. Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology: 2010; 151 3169 3180
40. Tan B. K., Hallschmid M., Kern W., Lehnert H., Randeva H. S. Decreased cerebrospinal fluid/plasma ratio of the novel satiety molecule, nesfatin-1/NUCB-2, in obese humans: evidence of nesfatin-1/NUCB-2 resistance and implications for obesity treatment. J Clin Endocrinol Metab: 2011; 96 E669 E673
41. Abaci A., Catli G., Anik A., Kume T., Bober E. The relation of serum nesfatin-1 level with metabolic and clinical parameters in obese and healthy children. Pediatr Diabetes: 2013; 14 189 195
42. Kirchgessner A. L., Sclafani A. PVN-hindbrain pahway involved in the hypothalamic hyperphagia-obesity syndrome. Physiol Behav: 1988; 42 517 528
43. Schwartz M. W., Woods S. C., Porte D. Jr, Seeley R. J., Baskin D. G. Central nervous system control of food intake. Nature: 2000; 404 661 671 (Pubitemid 30205071)
44. Zorrilla E. P., Taché Y., Koob G. F. Nibbling at CRF receptor control of feeding and gastrocolonic motility. Trends Pharmacol Sci: 2003; 24 421 427 (Pubitemid 36952559)
45. Tabarin A., Diz-Chaves Y., Consoli D., Monsaingeon M., Bale T. L., Culler M. D., Datta R., Drago F., Vale W. W., Koob G. F., Zorrilla E. P., Contarino A. Role of the corticotropin-releasing factor receptor type 2 in the control of food intake in mice: a meal pattern analysis. Eur J Neurosci: 2007; 26 2303 2314 (Pubitemid 47620499)
46. Price C. J., Hoyda T. D., Samson W. K., Ferguson A. V. Nesfatin-1 influences the excitability of paraventricular nucleus neurones. J Neuroendocrinol: 2008; 20 245 250 (Pubitemid 351147011)
47. Gotoh K., Masaki T., Chiba S., Ando H., Shimasaki T., Mitsutomi K., Fujiwara K., Katsuragi I., Kakuma T., Sakata T., Yoshimatsu H. Nesfatin-1, corticotropin-releasing hormone, thyrotropin-releasing hormone, and neuronal histamine interact in the hypothalamus to regulate feeding behavior. J Neurochem: 2013; 124 90 99
48. Konczol K., Bodnar I., Zelena D., Pinter O., Papp R. S., Palkovits M., Nagy G. M., Toth Z. E. Nesfatin-1/NUCB2 may participate in the activation of the hypothalamic-pituitary-adrenal axis in rats. Neurochem Int: 2010; 57 189 197
49. Hashimoto K., Nishiyama M., Tanaka Y., Noguchi T., Asaba K., Hossein P. N., Nishioka T., Makino S. Urocortins and corticotropin releasing factor type 2 receptors in the hypothalamus and the cardiovascular system. Peptides: 2004; 25 1711 1721 (Pubitemid 39346213)
50. Nonogaki K., Ohba Y., Sumii M., Oka Y. Serotonin systems upregulate the expression of hypothalamic NUCB2 via 5-HT2C receptors and induce anorexia via a leptin-independent pathway in mice. Biochem Biophys Res Commun: 2008; 372 186 190
51. Price C. J., Samson W. K., Ferguson A. V. Nesfatin-1 inhibits NPY neurons in the arcuate nucleus. Brain Res: 2008; 1230 99 106